(Q80987578)
Statements
Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials (English)
Andrew J Palmer
Stéphane Roze
William J Valentine
Inger Smith
Kim U Wittrup-Jensen
1 November 2004